Antoxis Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Antoxis General Information

Description

Developer of a drug discovery platform intended to maximize the clinical outcomes of regenerative medicine therapies. The company's platform utilizes its patented Kromex chemistry scaffold to generate New Chemical Entities (NCE) that protects over 100 million compounds, enabling physicians to treat neurodegenerative diseases and cancer.

Contact Information

Website
www.antoxis.com
Formerly Known As
Aoxtherapeutics Limited
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • IMS Building
  • Foresterhill Health and Research Complex
  • Aberdeen AB25 2ZD
  • Scotland, United Kingdom
+44 01224
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • IMS Building
  • Foresterhill Health and Research Complex
  • Aberdeen AB25 2ZD
  • Scotland, United Kingdom
+44 01224

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Antoxis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 29-Dec-2020 Completed Out of Business
3. Later Stage VC 10-May-2013 Completed Generating Revenue
2. Grant 31-Jul-2010 $283K Completed Generating Revenue
1. Early Stage VC 19-Jan-2010 $283K $283K Completed Generating Revenue
To view Antoxis’s complete valuation and funding history, request access »

Antoxis Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary 2
Ordinary 1
To view Antoxis’s complete cap table history, request access »

Antoxis Patents

  • 34

    Total Documents Applications and Grants

  • Total Patents Families

  • 10

    Granted

  • Pending

  • Expiring in next 12 mo

Antoxis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2627646-A1 Compound Inactive 13-Oct-2010
GB-201017315-D0 Compound Inactive 13-Oct-2010
US-20130267586-A1 Compound Active 13-Oct-2010
WO-2012049460-A1 Compound Inactive 13-Oct-2010
CA-2757716-A1 Use of compounds for differentiation of cells Inactive 09-Apr-2009 C12N5/0606
To view Antoxis’s complete patent history, request access »

Ready to get started?

Request a free trial

Antoxis FAQs

  • When was Antoxis founded?

    Antoxis was founded in 2005.

  • Where is Antoxis headquartered?

    Antoxis is headquartered in Aberdeen, United Kingdom.

  • What industry is Antoxis in?

    Antoxis’s primary industry is Drug Discovery.

  • Is Antoxis a private or public company?

    Antoxis is a Private company.

  • What is Antoxis’s current revenue?

    The current revenue for Antoxis is .

  • How much funding has Antoxis raised over time?

    Antoxis has raised $707K.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process